We are live on ! Find out more
CYTK icon

Cytokinetics
CYTK

134 hedge funds and large institutions have $502M invested in Cytokinetics in 2019 Q2 according to their latest regulatory filings, with 16 funds opening new positions, 70 increasing their positions, 23 reducing their positions, and 18 closing their positions.

New
Increased
Maintained
Reduced
Closed

671% more call options, than puts

Call options by funds: $7.07M | Put options by funds: $917K

204% more repeat investments, than reductions

Existing positions increased: 70 | Existing positions reduced: 23

55% more capital invested

Capital invested by funds: $324M → $502M (+$178M)

4.5% more ownership

Funds ownership: 72.87% → 77.37% (+4.5%)

0% more funds holding in top 10

Funds holding in top 10: 3 → 3 (0)

3% less funds holding

Funds holding: 138 → 134 (-4)

11% less first-time investments, than exits

New positions opened: 16 | Existing positions closed: 18

Holders
134
Holders Change
-4
Holders Change %
-2.9%
% of All Funds
2.91%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
16
Increased
70
Reduced
23
Closed
18
Calls
$7.07M
Puts
$917K
Net Calls
+$6.15M
Net Calls Change
+$5.98M

Top Buyers

1
DCM
Driehaus Capital Management
Illinois
+$21.1M
2
BI
BVF Inc
California
+$13.3M
3
Millennium Management
Millennium Management
New York
+$10M
4
Point72 Asset Management
Point72 Asset Management
Connecticut
+$5.85M
5
State Street
State Street
Massachusetts
+$3.61M

Top Sellers

1
LPU
Lansdowne Partners (UK)
United Kingdom
-$11.8M
2
Fidelity Investments
Fidelity Investments
Massachusetts
-$2.49M
3
Jacobs Levy Equity Management
Jacobs Levy Equity Management
New Jersey
-$1.78M
4
SDIC
South Dakota Investment Council
South Dakota
-$1.65M
5
Goldman Sachs
Goldman Sachs
New York
-$1.29M
Name Holding Trade Value Shares
Change 		Change in
Stake
TRSOTSOK
101
Teachers Retirement System of the State of Kentucky
Kentucky
$120K – – –
AB
102
Amalgamated Bank
New York
$115K +$98.9K +10,259 New
NA
103
Neuburgh Advisers
California
$114K – – –
BC
104
Birchview Capital
Vermont
$113K – – –
MAM
105
Meeder Asset Management
Ohio
$112K +$77.3K +8,011 +404%
Walleye Capital
106
Walleye Capital
New York
$108K +$92.6K +9,600 New
Bank of Montreal
107
Bank of Montreal
Ontario, Canada
$90K +$44.6K +4,628 +139%
PNC Financial Services Group
108
PNC Financial Services Group
Pennsylvania
$84K +$6.67K +692 +10%
MCIM
109
Meadow Creek Investment Management
Georgia
$83K – – –
PI
110
PineBridge Investments
New York
$73K +$4.86K +504 +8%
BNP Paribas Financial Markets
111
BNP Paribas Financial Markets
France
$57.5K -$43K -4,464 -47%
AIP
112
Ameritas Investment Partners
Nebraska
$53K +$10K +1,038 +28%
Group One Trading
113
Group One Trading
Illinois
$37K +$17.4K +1,807 +120%
LTFS
114
Ladenburg Thalmann Financial Services
Florida
$30K -$67.5K -7,000 -72%
Zurich Cantonal Bank
115
Zurich Cantonal Bank
Switzerland
$26K – – –
SWA
116
Sutton Wealth Advisors
Florida
$24.9K – – –
Royal Bank of Canada
117
Royal Bank of Canada
Ontario, Canada
$23K +$68 +7 +0.3%
MOACM
118
Mutual of America Capital Management
New York
$23K +$4.94K +512 +33%
LIA
119
LS Investment Advisors
Michigan
$21K – – –
GWM
120
Geneos Wealth Management
Colorado
$11K – – –
QT
121
Quantbot Technologies
New York
$7K +$6.75K +700 New
WAP
122
Wealthcare Advisory Partners
Pennsylvania
$5K +$3.95K +410 New
FDCDDQ
123
Federation des caisses Desjardins du Quebec
Quebec, Canada
$4.5K – – –
Daiwa Securities Group
124
Daiwa Securities Group
Japan
$4K +$627 +65 +22%
VCM
125
Versant Capital Management
Arizona
$3K +$2.47K +256 +316%
2 3 4
5
6

CYTK Hedge Fund Activity: Q2 2019 in Review

134 of the 4,604 institutional investors tracked by Wall St. Rank reported a position in Cytokinetics (CYTK) for Q2 2019, worth a combined $502M — up 55% from $324M a quarter earlier.

Sellers outnumbered buyers: 18 funds closed out of CYTK and 16 opened new positions — a net loss of 2 holders — while 23 trimmed existing stakes and 70 added.

The largest buyer was Driehaus Capital Management, opening a new position worth an estimated $21.1M. The largest seller was Lansdowne Partners (UK), exiting entirely with an estimated $11.8M sold.

  • 134 institutional investors held Cytokinetics (CYTK) as of Q2 2019, down from 138 in Q1 2019.
  • Funds reported $502M of Cytokinetics stock for Q2 2019, up 55% quarter-over-quarter.
  • 16 funds opened new Cytokinetics positions in Q2 2019 and 18 closed out, a net change of -2 holders.
  • The largest Cytokinetics buyer in Q2 2019 was Driehaus Capital Management, an estimated $21.1M added.
  • The largest Cytokinetics seller in Q2 2019 was Lansdowne Partners (UK), an estimated $11.8M sold.

Based on aggregated 13F filings for Q2 2019.